company background image
A048410 logo

Hyundai Bioscience KOSDAQ:A048410 Stock Report

Last Price

₩14.07k

Market Cap

₩560.3b

7D

2.6%

1Y

-46.1%

Updated

27 Dec, 2024

Data

Company Financials

Hyundai Bioscience Co., Ltd.

KOSDAQ:A048410 Stock Report

Market Cap: ₩560.3b

A048410 Stock Overview

Operates as a biotechnology company. More details

A048410 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Hyundai Bioscience Co., Ltd. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Hyundai Bioscience
Historical stock prices
Current Share Price₩14,070.00
52 Week High₩26,350.00
52 Week Low₩12,650.00
Beta1.07
1 Month Change-4.09%
3 Month Change-27.47%
1 Year Change-46.09%
3 Year Change-44.28%
5 Year Change1.96%
Change since IPO21.29%

Recent News & Updates

Hyundai Bioscience Co., Ltd.'s (KOSDAQ:048410) Stock Retreats 26% But Revenues Haven't Escaped The Attention Of Investors

Dec 05
Hyundai Bioscience Co., Ltd.'s (KOSDAQ:048410) Stock Retreats 26% But Revenues Haven't Escaped The Attention Of Investors

Is Hyundai Bioscience (KOSDAQ:048410) A Risky Investment?

Nov 12
Is Hyundai Bioscience (KOSDAQ:048410) A Risky Investment?

Recent updates

Hyundai Bioscience Co., Ltd.'s (KOSDAQ:048410) Stock Retreats 26% But Revenues Haven't Escaped The Attention Of Investors

Dec 05
Hyundai Bioscience Co., Ltd.'s (KOSDAQ:048410) Stock Retreats 26% But Revenues Haven't Escaped The Attention Of Investors

Is Hyundai Bioscience (KOSDAQ:048410) A Risky Investment?

Nov 12
Is Hyundai Bioscience (KOSDAQ:048410) A Risky Investment?

The Trends At Hyundai Bioscience (KOSDAQ:048410) That You Should Know About

Mar 14
The Trends At Hyundai Bioscience (KOSDAQ:048410) That You Should Know About

Is Hyundai Bioscience (KOSDAQ:048410) Using Too Much Debt?

Feb 07
Is Hyundai Bioscience (KOSDAQ:048410) Using Too Much Debt?

Imagine Holding Hyundai Bioscience (KOSDAQ:048410) Shares While The Price Zoomed 439% Higher

Jan 03
Imagine Holding Hyundai Bioscience (KOSDAQ:048410) Shares While The Price Zoomed 439% Higher

The Trends At Hyundai Bioscience (KOSDAQ:048410) That You Should Know About

Nov 29
The Trends At Hyundai Bioscience (KOSDAQ:048410) That You Should Know About

Shareholder Returns

A048410KR Personal ProductsKR Market
7D2.6%-1.1%-0.5%
1Y-46.1%-14.0%-11.6%

Return vs Industry: A048410 underperformed the KR Personal Products industry which returned -14% over the past year.

Return vs Market: A048410 underperformed the KR Market which returned -11.6% over the past year.

Price Volatility

Is A048410's price volatile compared to industry and market?
A048410 volatility
A048410 Average Weekly Movement8.2%
Personal Products Industry Average Movement7.5%
Market Average Movement6.6%
10% most volatile stocks in KR Market12.7%
10% least volatile stocks in KR Market3.3%

Stable Share Price: A048410 has not had significant price volatility in the past 3 months compared to the KR market.

Volatility Over Time: A048410's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
200054Jong-Won Choiwww.hyundaibioscience.com

Hyundai Bioscience Co., Ltd. operates as a biotechnology company. The company provides Vitabrid C12, a vitamin C product that delivers active vitamin C into the skin. It develops Polytaxel, a drug for pancreatic cancer and solid tumors; and CP-COV03 drug for Covid 19.

Hyundai Bioscience Co., Ltd. Fundamentals Summary

How do Hyundai Bioscience's earnings and revenue compare to its market cap?
A048410 fundamental statistics
Market cap₩560.26b
Earnings (TTM)-₩10.44b
Revenue (TTM)₩15.82b

35.4x

P/S Ratio

-53.7x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A048410 income statement (TTM)
Revenue₩15.82b
Cost of Revenue₩3.81b
Gross Profit₩12.01b
Other Expenses₩22.45b
Earnings-₩10.44b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-262.18
Gross Margin75.90%
Net Profit Margin-66.00%
Debt/Equity Ratio57.6%

How did A048410 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/27 19:16
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Hyundai Bioscience Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution